Inhaled Insulin

2006/07/31 16:57

Press Release from:

rxchemist.co.uk

The first inhaled insulin is now available from rxchemist.co.uk website.

Nearly 21 million Americans and 48 million Europeans have diabetes.(*) Despite existing therapies for diabetes, millions of patients don’t achieve or maintain acceptable blood sugar levels. Complications from uncontrolled or poorly controlled blood sugar levels in diabetes patients can include heart disease, amputation, blindness and kidney failure.

In type 2 diabetes, which represents 95 percent of patients, the body does not make or use insulin well enough to manage blood sugar levels. Type 2

Health through Care

diabetes progresses over time, and eventually most patients will need to administer insulin to achieve blood sugar control. In type 1 diabetes, the body does not make insulin at all. These patients must take insulin to survive.

Exubera® is a rapid-acting, dry powder human insulin that is inhaled through the mouth into the lungs prior to eating, using the handheld Exubera® Inhaler. The Exubera® Inhaler weighs four ounces and, when closed, is about the size of an eyeglass case. The unique Exubera® Inhaler produces a cloud of insulin powder in a clear chamber visible to the patient. This insulin powder is designed to pass rapidly into the bloodstream to regulate the body’s blood sugar levels.

Exubera® is approved in both the U.S. and the EU for adults with type 1 and type 2 diabetes